Xeloda

Capecitabine

6.8 High risk

Xeloda & Palmar-plantar erythrodysaesthesia syndrome

6.7%

of users reported Palmar-plantar erythrodysaesthesia syndrome

73.1%

also reported Severe reaction

73.9%

are women

Most common medical consequences

Severe reaction
73.1%
Hospitalization
13.8%
Death
7.5%
Disability
4.4%
Life-threatening condition
1.2%

Have you experienced any negative side effects from this medication?

Xeloda: general information

Most common side effects (312)

Most commonly affected ages

20 - 29 years
0.6%
30 - 39 years
4.7%
40 - 49 years
13.0%
50 - 59 years
26.2%
60 - 69 years
30.3%
70 - 79 years
19.2%
80 - 89 years
5.7%
90 - 99 years
0.2%